| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/24/2003 | US6583319 Cyclic compounds having a cycloalkylene chain |
| 06/24/2003 | US6583311 Stable NO-delivering compounds |
| 06/24/2003 | US6583309 Ureas and compositions thereof for treating cancer, inflammation, or a viral infection |
| 06/24/2003 | US6583301 Lipids |
| 06/24/2003 | US6583299 α-amino-β-sulfonyl hydroxamic acid compounds |
| 06/24/2003 | US6583296 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and α-1-blocking action |
| 06/24/2003 | US6583290 14-methyl epothilone derivatives |
| 06/24/2003 | US6583288 Hydantoin-containing glucokinase activators |
| 06/24/2003 | US6583283 Polymorphic forms of cipamfylline |
| 06/24/2003 | US6583274 Crystalline forms of macrolide antibiotic |
| 06/24/2003 | US6583219 Three-dimensional, crosslinked interpenetrating polymer network |
| 06/24/2003 | US6583184 Topical compositions; plant extract |
| 06/24/2003 | US6583182 Atomic numbers 21-30 are components of enzymes required for nucleic acid replication; substituted polyaza compounds inhibit cell replication by decreaseing bioavailability of iron or copper |
| 06/24/2003 | US6583181 Antimicrobial quaternary ammonium compositions with reduced ocular irritation |
| 06/24/2003 | US6583179 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone |
| 06/24/2003 | US6583174 Bi-cyclic compound dissolved in a glyceride; 7-((1R,3R,6R,7R)-3-(1,1-difluoropentyl)-3-hydroxy-2-oxabicyclo(4,3,0)nonane -8-one-7-yl)heptanoic acid |
| 06/24/2003 | US6583173 Useful as anticoagulants in mammals; inhibitors of factor Xa |
| 06/24/2003 | US6583172 Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders |
| 06/24/2003 | US6583171 Antineoplastic agents |
| 06/24/2003 | US6583170 Hormone replacement therapy to maintain the bone sparing effect while minimizing the proliferative effects in the uterus and breast; estrogen agonists/antagonists |
| 06/24/2003 | US6583167 Methods and kits for treating and diagnosing leiomyomas |
| 06/24/2003 | US6583166 Fewer side effects than D2 receptor antagonist neuroleptics; cardiovascular, kidney, central nervous system disorders; 3-(3-((4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)sulfanyl) propyl)-1,3,3a,4,5,9b-hexahydro-2H-benzo(e)indol-2-one |
| 06/24/2003 | US6583165 Anticarcinogenic, -inflammatory and -proliferative agents; viricides; bactericides; vascular restenosis, autoimmune diseases; psoriasis; anticolesterol and -lipemic agents |
| 06/24/2003 | US6583164 Lyophilized imidazole-1-yl or 1,2,4-triazole-1-yl quaternized with a alklycarbonyloxy alkyl group eliminated in vivo; a saccharide; 4-acetoxymethyl-1-(3-(2-oxo-3-(4-(1H-tetrazol-yl) phenyl)-1-imidazolydinyl)butyl)-1H-1,2,4-triazolium chloride |
| 06/24/2003 | US6583163 Agent for inhibition of cytokine production and agent for inhibition of cell adhesion |
| 06/24/2003 | US6583162 Chronic dermal ulcers, wound healing |
| 06/24/2003 | US6583160 Introducing nicotine into a user's bloodstream at a place where the the nicotine doses are carried to the brain before passing through the liver; pulsing dosage to mimic a puff of smoking; oral tablet; drug abuse |
| 06/24/2003 | US6583159 Substitute 1-(piperidin-4-yl)-3-(aryl)-isothioureas, their preparation and therapeutic use |
| 06/24/2003 | US6583158 Method for enhancing mutant enzyme activities in lysosomal storage disorders |
| 06/24/2003 | US6583156 Particularly adenosine A2A receptors; neurodegenerative disorders; 2,8-bis(trifluoromethyl)-alpha -(3-thienyl)-4-quinolinemethanol |
| 06/24/2003 | US6583155 Administering 2-(1-(3-(5-Acetyl-3-(4-chloro-phenyl)-4,5,6,7-tetrahydro-pyrazolo-(4,3 -c)pyridin-1-yl)-2-hydroxy-propyl)-piperidin-4-ylamino)-benzonitrile for inhibiting cathepsins; for treating atopic diseases |
| 06/24/2003 | US6583154 Compounds and methods which modulate feeding behavior and related diseases |
| 06/24/2003 | US6583153 7-heterocyclyl quinoline and thieno[2,3-b]yridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 06/24/2003 | US6583152 Composition for reducing the risk or progression of cardiovascular diseases |
| 06/24/2003 | US6583151 Remedies for drug addiction |
| 06/24/2003 | US6583150 Cytotoxic propertie; antitumor; pyrido-(3,2-g)quinoline-5,10-diones; benzo(b)pyrido(4,3,2-de)(1,7)-phenanthroline-8-ones |
| 06/24/2003 | US6583149 2-hydroxymethyl-4-(cytosin-1'-yl)-1,3-Dioxolane |
| 06/24/2003 | US6583148 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine |
| 06/24/2003 | US6583147 Pyrazolopyrimidinone derivatives for the treatment of impotence |
| 06/24/2003 | US6583146 Thiazolopyrimidine compounds, its production and use |
| 06/24/2003 | US6583145 Thio-oxindole derivatives |
| 06/24/2003 | US6583143 CRF receptor antagonists and methods relating thereto |
| 06/24/2003 | US6583141 T cell mediated rheumatic diseases |
| 06/24/2003 | US6583140 2-substituted thiazolidinones as beta-3 adrenergic receptor agonists |
| 06/24/2003 | US6583139 Treatment of inflammatory diseases; inflammatory brain diseases such as multiple sclerosis; N-(Toluene-4-sulfonyl)-L-prolyl-4-(alpha -methylbenzyloxy)-L-phenylalanine; Very Late Antigen 4 |
| 06/24/2003 | US6583137 Protease inhibitors |
| 06/24/2003 | US6583136 Antifungal ethers |
| 06/24/2003 | US6583135 Substituted azepino[4,5b]indole derivatives |
| 06/24/2003 | US6583134 Aza- indolyl derivatives for treating obesity |
| 06/24/2003 | US6583133 Especially against Gram-positive organisms, e.g. methicillin-sensitive (MSSA) and methicillin- resistant (MRSA) staphylococci, enterococci and pneumococci |
| 06/24/2003 | US6583132 Oxidant scavengers |
| 06/24/2003 | US6583131 Cationic cholesteryl derivatives containing cyclic polar groups |
| 06/24/2003 | US6583130 C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compounds |
| 06/24/2003 | US6583129 Administration of non-oral androgenic steroids to women |
| 06/24/2003 | US6583128 Immunoregulatory compounds and derivatives and methods of treating diseases therewith |
| 06/24/2003 | US6583127 Administering phosphatides such as 1-O-octadecyl-2-O-methyl glycero-3-phosphocholine, enantiomers and/or stereisomers as antiinflammatory agents for prophylaxis of inflammatory bowel disease, gastrointestinal or respiratory system disorders |
| 06/24/2003 | US6583126 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B) |
| 06/24/2003 | US6583124 For controlled administration of pharmaceutically active agents to patients, wherein formulation is administered as liquids which thicken to form gels upon instillation into the eye |
| 06/24/2003 | US6583123 Aminosugar, glycosaminoglycan, and S-adenosylmethionine composition for the treatment and repair of connective tissue |
| 06/24/2003 | US6583122 Use in boron neutron capture therapy (BNCT) and diagnostic purposes; treating cancer, viral infections such as HIV, hepatitis B virus |
| 06/24/2003 | US6583121 System for the in vivo delivery and expression of heterologous genes in the bone marrow |
| 06/24/2003 | US6583119 Aromatic antibiotics such as 7-((6-deoxy-5-methyl-4-methyl-hexopyranosyl)oxy)-4-hydroxy-8-methyl-3-(1 -(phenoxyimino) ethyl)-2H-1-benzopyran-2-one (2-propynyloxy)-carbamic 3'-ester acid, for prevention of grampositive bacterial infections |
| 06/24/2003 | US6583118 Chondroprotective agents |
| 06/24/2003 | US6582961 Generating disease resistant plants; obtain plant, incubate with vector coding preferential enzymatic polypeptides, transform, recover transformed plants, propagate, monitor plant resistance to disease |
| 06/24/2003 | US6582918 Platelet derived growth factor (PDGF) nucleic acid ligand complexes |
| 06/24/2003 | US6582747 Dry cocoa mix containing a mixture of non-alkalized and alkalized cocoa solids |
| 06/24/2003 | US6582737 Pharmaceutical composition containing two active ingredients for smoking cessation |
| 06/24/2003 | US6582735 Compositions and methods of use for extracts of magnoliaceae plants |
| 06/24/2003 | US6582734 Antimicrobial composition useful for the treatment of bovine mastitis |
| 06/24/2003 | US6582728 On carrier of human serum albumin, carbohydrate, amino acid, polypeptide, buffer and/or salts; drug delivery to lungs |
| 06/24/2003 | US6582724 Enhancing permeation of skin or mucosal tissue with topical hydroxide- releasing agent and lipophilic co-enhancer |
| 06/24/2003 | US6582723 Cancer immune composition for prevention and treatment of individuals |
| 06/24/2003 | US6582721 Stable carotene-xanthophyll beadlet compositions and methods of use |
| 06/24/2003 | US6582717 Drug delivery composition and device |
| 06/24/2003 | US6582705 Acellular antibordetella vaccine |
| 06/24/2003 | US6582690 Process for treating tumors with cytotoxic substances |
| 06/24/2003 | US6582689 Interferon- gamma -inducing factor (IGIF), in combination with a chemotherapeutic agent, processes for making such compositions, the use of such compositions for the prevention and/or treatment of cancer, and the use of such compositions |
| 06/24/2003 | US6582688 Method for extracting compounds of furan lipids and polyhydroxylated fatty alcohols of avocado, composition based on said compounds, and therapeutic, cosmetical or food use of said compounds |
| 06/24/2003 | US6582687 Weak acid skin cleanser |
| 06/24/2003 | US6582677 Pressurized aerosol composition comprising a liquefied hydrofluorocarbon propellant of formula CxHyFz where x is an integer from 1 to 3, y+z=2x+2, and y and z are both at least 1; from 0.01 to 15% w/w of a particulate medicament dispersed |
| 06/24/2003 | US6582457 Method of controlling body temperature while reducing shivering |
| 06/24/2003 | US6582351 Benzimidazole heterocyclic compounds having pharmacological activities, and their use as a medicament for treatment or prevention of diseases mediated by cGMP-PDE |
| 06/24/2003 | US6581773 Weight-specific elixir dosage calculator |
| 06/24/2003 | CA2343439C Compositions useful in the treatment of diseases of connective tissues |
| 06/24/2003 | CA2288910C Pyrazolopyrimidinones for sexual dysfunction |
| 06/24/2003 | CA2272014C N-aryl/heteroaryl-substituted heterocycles |
| 06/24/2003 | CA2179015C Use of bis(amidinobenzimidazoles) in the manufacture of medicament for inhibiting retroviral integrase |
| 06/24/2003 | CA2171544C Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains |
| 06/24/2003 | CA2130805C Use of mannose phosphates for the treatment of fibrotic disorders |
| 06/24/2003 | CA2108794C Use of torasemide for the treatment of brain oedemas |
| 06/24/2003 | CA2087251C Pharmaceutical compositions |
| 06/21/2003 | CA2414905A1 N-(cyclopropylmethyl)azacycloalkanes, compositions containing them and methods of preparation |
| 06/21/2003 | CA2365806A1 Improved polymer-lipid delivery vehicles |
| 06/19/2003 | WO2003050504A2 Methods and compositions to treat cardiovascular disease usin g 1419, 58765 and 2201 |
| 06/19/2003 | WO2003050502A2 Prospective identification and characterization of breast cancer stem cells |
| 06/19/2003 | WO2003050311A2 Methods and compositions for diagnosing and treating hypotrichosis simplex |
| 06/19/2003 | WO2003050309A1 ANTISENSE MODULATION OF PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASE, Iα EXPRESSION |
| 06/19/2003 | WO2003050301A2 Susceptibility locus for schizophrenia |
| 06/19/2003 | WO2003050295A2 Assays and implements for determining and modulating hsp90 binding activity |
| 06/19/2003 | WO2003050257A2 Targeting leukemia cells |